Document is current
Any future updates will be listed below
-
Authors
Liu, Yuan https://orcid.org/0000-0001-5031-7514
Jurczak, Michael J.
Lear, Travis B. https://orcid.org/0000-0001-9156-0844
Lin, Bo https://orcid.org/0000-0002-2108-2696
Larsen, Mads B.
Kennerdell, Jason R.
Chen, Yanwen https://orcid.org/0000-0002-3467-2871
Huckestein, Brydie R.
Nguyen, Matthew K.
Tuncer, Ferhan
Jiang, Yu https://orcid.org/0000-0003-4746-1528
Monga, Satdarshan P. https://orcid.org/0000-0002-8437-3378
O’Donnell, Christopher P.
Finkel, Toren https://orcid.org/0000-0002-0726-3546
Chen, Bill B.
Mallampalli, Rama K. https://orcid.org/0000-0002-5782-4495
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (HL081784)
- License Information
-
More Information
Article History
Received: 10 September 2018
Revised: 27 October 2020
Accepted: 14 December 2020
First Online: 25 January 2021
Competing interests
: A provisional patent application (US patent 62/404,592) has been converted to a Patent Cooperation Treaty application jointly by the US Department of Veterans Affairs and the University of Pittsburgh covering all chemical entities included in this study. Y.L., T.F. and B.B.C. are the founders and employees of Generian Pharmaceuticals and may own company stock.
